Apr 4, 2022

How a Seagen cancer drug with Nobel Prize science might also work in diabetes

Posted by in categories: biotech/medical, science

Some diabetes therapies work by ramping up the body’s secretion of insulin to counteract high blood sugar levels. | Preserving insulin-producing pancreatic beta cells—rather than exhausting them—might be a better strategy in the treatment of diabetes. Following that thinking, scientists at the Karolinska Institute found a cancer drug by Seagen holds promise for the metabolic disease.

Comments are closed.